Infliximab for Crohn's disease: more questions than answers

Can J Gastroenterol. 2001 Jun;15(6):360-2. doi: 10.1155/2001/453524.
No abstract available

Publication types

  • Comment
  • Editorial

MeSH terms

  • Antibodies, Monoclonal / immunology
  • Antibodies, Monoclonal / therapeutic use*
  • Canada
  • Crohn Disease / drug therapy*
  • Crohn Disease / immunology*
  • Gastrointestinal Agents / immunology*
  • Gastrointestinal Agents / therapeutic use*
  • Humans
  • Infliximab
  • Treatment Outcome

Substances

  • Antibodies, Monoclonal
  • Gastrointestinal Agents
  • Infliximab